Avian Flu Treatment Market Report 2026

Avian Flu Treatment Market Overview

• Avian Flu Treatment market size has reached to $13.77 billion in 2025 • Expected to grow to $20.6 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Growing Awareness And Diagnosis Drive Avian Flu Treatment Market Growth • Market Trend: Strategic Partnerships Drive Innovation In Avian Flu Treatment And Vaccine Development • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Avian Flu Treatment Market?

Avian flu treatment refers to the medical interventions and strategies aimed at managing and alleviating the symptoms of avian influenza, commonly known as bird flu, in infected individuals. Avian influenza is caused by viruses that primarily infect birds, but certain strains, such as H5N1 and H7N9, have been known to infect humans and cause severe illness or even death in some cases. The main types of avian flu treatment are antibiotics, vaccines, antiviral agents, and immunoglobulins. Antibiotics are drugs used to treat bacterial infections. The distribution channel includes online pharmacies and offline pharmacies and it is used by various end-users such as hospitals, institutional health centers, and clinics.

What Is The Avian Flu Treatment Market Growth Forecast?

The avian flu treatment market size is expected to see strong growth in the next few years. It will grow to $20.6 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing investments in zoonotic disease research, rising development of next-generation vaccines, expansion of global disease surveillance networks, growing focus on rapid response therapeutics, increased international collaboration on pandemic preparedness. Major trends in the forecast period include increasing adoption of advanced antiviral therapies, rising focus on rapid vaccine development platforms, growing use of monoclonal antibody treatments, expansion of early diagnosis and surveillance programs, enhanced focus on pandemic preparedness.

Global Avian Flu Treatment Market Segmentation

1) By Type: Vaccines, Antiviral Agents, Immunoglobulins 2) By Distribution Channel: Online Pharmacies, Offline Pharmacies 3) By End User: Hospital, Institutional Health Centers, Clinics Subsegments: 1) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Subunit Vaccines, Dna Vaccines, Bivalent And Multivalent Vaccines 2) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir), Polymerase Inhibitors, Antiviral Combination Therapies 3) By Immunoglobulins: Human Immunoglobulin (Ivig), Monoclonal Antibodies, Hyperimmune Serum, Polyvalent Immunoglobulins, Avian Flu-Specific Immunoglobulins

What Is The Driver Of The Avian Flu Treatment Market?

The growing awareness and diagnosis are expected to drive the growth of the avian flu treatment market going forward. Awareness is the recognition of a condition, while diagnosis is the identification of a specific issue based on that awareness. The demand for avian flu treatment arises from the urgent need to safeguard public health, prevent potential pandemics, and protect poultry populations from significant economic losses. Awareness and early diagnosis are crucial for effective avian flu treatment, enabling prompt intervention and containment to prevent spread. For instance, in April 2024, as per the World Health Organization (WHO), a Switzerland-based intergovernmental organization, more than 8000 people were under active surveillance in the US from February 9, 2022, to March 29, 2024, after being exposed to animals thought to be HPAI A (H5N1) virus-infected. Therefore, growing awareness and diagnosis are driving growth in the avian flu treatment industry.

Key Players In The Global Avian Flu Treatment Market

Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline Plc, Novartis AG, AstraZeneca Plc, Gilead Sciences Inc., CSL Limited, Moderna Inc., Shionogi & Co. Ltd., Cipla Ltd., Seqirus, Novavax Inc., Sinovac Biotech Ltd., Valneva SE, CureVac AG, BioCryst Pharmaceuticals Inc., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Baxter International Inc., Takeda Pharmaceutical Company Limited

Global Avian Flu Treatment Market Trends and Insights

Major companies in the avian flu treatment market are focusing on creating partnerships to enhance efficacy and speed up the development of new treatments. Partnerships involve collaborations between pharmaceutical companies, research institutions, and government agencies to pool resources, share expertise, and conduct innovative clinical trials. For instance, in April 2024, CureVac N.V., a Germany-based biotechnology company, partnered with GSK plc, a UK-based pharmaceutical company, to create an investigative influenza A (H5N1) pre-pandemic vaccine candidate to address the potential future pandemic threat posed by the H5N1 avian influenza virus. This collaboration aims to evaluate the safety, reactogenicity, and immunogenicity of the monovalent vaccine candidate, which encodes an influenza A H5 antigen using CureVac's proprietary second-generation mRNA backbone. The combined Phase 1/2 study will assess the vaccine candidate's safety and effectiveness in healthy adults aged 18 to 64 as well as in older adults aged 65 to 85.

What Are Latest Mergers And Acquisitions In The Avian Flu Treatment Market?

In November 2025, Merck & Co. (MSD), a U.S.-based biopharmaceutical company, agreed to acquire Cidara Therapeutics, Inc. for $9.2 billion in cash. With this acquisition, Merck aims to diversify and strengthen its respiratory and antiviral portfolio by integrating Cidara’s proprietary long-acting antiviral, CD388, designed for broad and durable influenza prevention. Cidara Therapeutics, a U.S.-based company, develops drug-Fc conjugate (DFC) therapeutics using its Cloudbreak platform, and its lead candidate CD388 is a strain-agnostic, investigational antiviral currently in Phase III trials.

Regional Outlook

North America was the largest region in the avian flu treatment market in 2025. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Avian Flu Treatment Market?

The avian flu treatment market consists of sales of antiviral medications, respiratory support equipment, and intravenous fluids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Avian Flu Treatment Market Report 2026?

The avian flu treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the avian flu treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.